Rapport Therapeutics, Inc. RAPP Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s retained earnings?
- Rapport Therapeutics, Inc. (RAPP) reported retained earnings of -$255.09M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s retained earnings changed year-over-year?
- Rapport Therapeutics, Inc.'s retained earnings decreased by 72.6% year-over-year, from -$147.81M to -$255.09M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s retained earnings?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s retained earnings has grown at a 127.5% compound annual growth rate (CAGR), from -$45.44M to -$235.23M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.